Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Expanded H-BIG clinical development program announced

Aug. 30, 1996

OP-1 role in kidney formation investigated

Aug. 30, 1996

Taisho discloses agents for urinary incontinence

Aug. 30, 1996

Reliance approved for marketing in U.S.

Aug. 30, 1996

Potential BPH therapeutics from Poli Industria Chimica

Aug. 30, 1996

U.S. agreement announced for ProstaFlo

Aug. 30, 1996

Terazosin and finasteride go head-to-head in BPH patients

Aug. 30, 1996

McGill University researchers improve safety of cell therapy

Aug. 23, 1996

Bioniche seeks U.S. approval to begin Cystistat clinical trials

Aug. 23, 1996

Boston Scientific to distribute Urologix technology

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...